CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomy
Authors:
- 25 July 2012
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 44 (6) , 1663-1669
Abstract
Objectives To investigate whether CD146 gene expression could provide useful information to predict early recurrence after nephrectomy. Methods This study included 84 patients with clear cell renal cell carcinoma (cRCC), and 44 subjects without tumor were used as controls. Quantitative RT-PCR was used to measure the CD146 gene expression. Results The mean value of CD146 expression in patients with metastatic cRCC (0.0438 ± 0.0024) was significantly higher than in those with localized cRCC (0.0374 ± 0.0012, P = 0.018) or in controls (0.0344 ± 0.0010, P = 0.001). Of patients with localized cRCC, those with recurrence had a significantly higher CD146 expression than those without recurrence (P = 0.029). The univariate analysis showed that CD146 was associated with early recurrence. The recurrence-free survival curve indicated that patients with a high CD146 expression had a significantly higher recurrence rate than those with a low CD146 expression (P = 0.018). Conclusions CD146 gene expression can be useful for predicting early recurrence and stratifying the patients into risk groups for possible adjuvant treatment.Keywords
This publication has 24 references indexed in Scilit:
- Targeting the Tumor Microenvironment: Focus on AngiogenesisJournal of Oncology, 2011
- Tumor Biology and Prognostic Factors in Renal Cell CarcinomaThe Oncologist, 2011
- Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?British Journal of Cancer, 2010
- Endothelial CD146 is required for in vitro tumor-induced angiogenesis: The role of a disulfide bond in signaling and dimerizationThe International Journal of Biochemistry & Cell Biology, 2009
- CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesBreast Cancer Research, 2009
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- M‐CAM expression as marker of poor prognosis in epithelial ovarian cancerInternational Journal of Cancer, 2006
- Novel approaches in the therapy of metastatic renal cell carcinomaWorld Journal of Urology, 2005
- Cell adhesion and signalling by cadherins and Ig-CAMs in cancerNature Reviews Cancer, 2004
- Identification of the S-Endo 1 Endothelial-Associated AntigenBiochemical and Biophysical Research Communications, 1996